Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Non-Invasive Screening for Fetal Aneuploidy
A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
Status: Enrolling
Updated:  12/31/1969
Obstetrix Medical Group of Houston
1867
mi
from 98109
The Woodlands, TX
Non-Invasive Screening for Fetal Aneuploidy
A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
Status: Enrolling
Updated: 12/31/1969
Obstetrix Medical Group of Houston
1867
mi
from 98109
The Woodlands, TX
Click here to add this to my saved trials
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
2024
mi
from 98109
Cleveland, OH
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
2
mi
from 98109
Seattle, WA
Family Access to Dentist Study
Family Intervention With Caregivers of Children With Dental Needs
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome: A Randomized, Double-blinded, Placebo-controlled Prospective Study
Status: Enrolling
Updated:  12/31/1969
University of Vermont Medical Center
2326
mi
from 98109
Burlington, VT
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome
Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome: A Randomized, Double-blinded, Placebo-controlled Prospective Study
Status: Enrolling
Updated: 12/31/1969
University of Vermont Medical Center
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
1029
mi
from 98109
Aurora, CO
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
1029
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status: Enrolling
Updated:  12/31/1969
SIUSOM - Division of Urology
1705
mi
from 98109
Springfield, IL
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status: Enrolling
Updated: 12/31/1969
SIUSOM - Division of Urology
1705
mi
from 98109
Springfield, IL
Click here to add this to my saved trials
Aging, Cognition, and Hearing Evaluation in Elders Study
Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Comstock Center for Public Health Research
2265
mi
from 98109
Hagerstown, MD
Aging, Cognition, and Hearing Evaluation in Elders Study
Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Comstock Center for Public Health Research
2265
mi
from 98109
Hagerstown, MD
Click here to add this to my saved trials
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
1780
mi
from 98109
Little Rock, AR
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
1780
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Lucile Packard Children's Hospital Stanford University
705
mi
from 98109
Palo Alto, CA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital Stanford University
705
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Lurie Children's Hospital- Chicago
1733
mi
from 98109
Chicago, IL
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Lurie Children's Hospital- Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
2315
mi
from 98109
Bethesda, MD
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute
2310
mi
from 98109
Rockville, MD
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute
2310
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
1892
mi
from 98109
Houston, TX
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
2322
mi
from 98109
Washington,
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
Status: Enrolling
Updated:  12/31/1969
UCSF School of Dentistry - Dental Offices in Bay Area
680
mi
from 98109
San Francisco, CA
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study
Status: Enrolling
Updated: 12/31/1969
UCSF School of Dentistry - Dental Offices in Bay Area
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Xanthohumol and Prevention of DNA Damage
Prevention of Oxidative DNA Damage by Xanthohumol
Status: Enrolling
Updated:  12/31/1969
Oregon State University
216
mi
from 98109
Corvallis, OR
Xanthohumol and Prevention of DNA Damage
Prevention of Oxidative DNA Damage by Xanthohumol
Status: Enrolling
Updated: 12/31/1969
Oregon State University
216
mi
from 98109
Corvallis, OR
Click here to add this to my saved trials
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
A Double-Blind, Placebo-Controlled Pilot Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Status: Enrolling
Updated:  12/31/1969
HealthPartners Neuroscience Center
1400
mi
from 98109
Saint Paul, MN
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
A Double-Blind, Placebo-Controlled Pilot Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Status: Enrolling
Updated: 12/31/1969
HealthPartners Neuroscience Center
1400
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Arizona Allergy Associates
1128
mi
from 98109
Chandler, AZ
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Arizona Allergy Associates
1128
mi
from 98109
Chandler, AZ
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
995
mi
from 98109
Irvine, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
995
mi
from 98109
Irvine, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University California San Diego - Rady's Children's Hospital
1065
mi
from 98109
San Diego, CA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University California San Diego - Rady's Children's Hospital
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Immunoe International Research
1032
mi
from 98109
Centennial, CO
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Immunoe International Research
1032
mi
from 98109
Centennial, CO
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Allergy Associate of the Palm Beaches
2687
mi
from 98109
North Palm Beach, FL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Allergy Associate of the Palm Beaches
2687
mi
from 98109
North Palm Beach, FL
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Ann and Robert H. Lurie Children's Hospital
1733
mi
from 98109
Chicago, IL
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Ann and Robert H. Lurie Children's Hospital
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Optimed Research, LTD
2001
mi
from 98109
Columbus, OH
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Optimed Research, LTD
2001
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Oklahoma Institute of Allergy & Asthma Clinical Research
1523
mi
from 98109
Oklahoma City, OK
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Oklahoma Institute of Allergy & Asthma Clinical Research
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Pennsylvania State University
2294
mi
from 98109
Hershey, PA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Pennsylvania State University
2294
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Dallas Allergy Immunology
1675
mi
from 98109
Dallas, TX
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Dallas Allergy Immunology
1675
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
AARA Research Center
1678
mi
from 98109
Dallas, TX
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
AARA Research Center
1678
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
O&O Alpan
2312
mi
from 98109
Fairfax, VA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
O&O Alpan
2312
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Bellingham Asthma Allergy Clinic
78
mi
from 98109
Bellingham, WA
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Bellingham Asthma Allergy Clinic
78
mi
from 98109
Bellingham, WA
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin/Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin/Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Minneapolis, MN
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
North Shore University Hospital
2414
mi
from 98109
Manhasset, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
2414
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
2403
mi
from 98109
New York, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
2403
mi
from 98109
New York, NY
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
North Austin Maternal Fetal Medicine
1770
mi
from 98109
Austin, TX
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
North Austin Maternal Fetal Medicine
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Cooper University Hospital
2375
mi
from 98109
Camden, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
2375
mi
from 98109
Camden, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Virtua
mi
from 98109
Mount Laurel, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Virtua
mi
from 98109
Mount Laurel, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
St. Peter's University
mi
from 98109
New Brunswick, NJ
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
St. Peter's University
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated:  12/31/1969
Complete Women's Healthcare
mi
from 98109
Garden City, NY
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
SNP-based Microdeletion and Aneuploidy RegisTry
Status: Enrolling
Updated: 12/31/1969
Complete Women's Healthcare
mi
from 98109
Garden City, NY
Click here to add this to my saved trials